Search results
CVS COVID-19 Vaccine Near Columbus OH
www.cvs.comPharmacy LocationBy appointment only5445 North High Street(614) 844-36993100 Cleveland Avenue(614) 263-09231500 Lockbourne Road(614) 449-9771933 Bethel Road(614) 459-95213499 Clime Road(614) 276-2651759 Neil Avenue(614) 224-92752100 East Dublin Granville Road(614) 891-1410Aug 27, 2021 · “The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed, and manufactured,” says Moderna’s CEO Stéphane Bancel.
Stéphane Bancel (born 20 July 1972) is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Jun 7, 2021 · Bancel reflects on the development timeline of the vaccine: from learning about the virus while reading the Wall Street Journal in 2019 to the moment he finally got his own shot at a Moderna facility. He talks about the promise of mRNA and what’s ahead for Moderna.
As Moderna's booster shots start to roll out across the country, Andy and Stéphane discuss the origins of Moderna's partnership with the government, how he thinks the vaccine will hold up against future variants, and the effort to vaccinate the globe.
Nov 16, 2020 · Stéphane Bancel is the CEO of Moderna, the company that translated the genetic code of the coronavirus into a vaccine. Moderna released results on Monday that said its vaccine is 94.5%...
Many in the scientific community view the move by Moderna as a betrayal. Today at RE:WIRED, our own senior writer Maryn McKenna sat down with Moderna’s CEO, Stéphane Bancel, along with Nahid Bhadelia, an internationally regarded infectious-disease physician.
Feb 7, 2024 · Today, the Company has 45 mRNA therapeutic and vaccine programs in its pipeline, nine of which are in late-stage development, and is known for developing one of the first and most effective COVID-19 vaccines. Before joining Moderna, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA.
